Qingjian Ou
- Cancer Research top 10%
- Ophthalmology top 5%
- Retinal Diseases and Treatments 9
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 9
- Colorectal Cancer Screening and Detection 7
-
- Retinal Development and Disorders 12
-
- Genetic factors in colorectal cancer 10
-
- Nutritional Studies and Diet 8
-
- Corneal Surgery and Treatments 8
-
- Diet and metabolism studies 7
- Cited by
- Cancer ResearchOphthalmologyOncology
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Qingjian Ou
74 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 306
- Ophthalmology 88
- Oncology 258
- Molecular Biology 575
- Immunology 120
Countries citing papers authored by Qingjian Ou
This map shows the geographic impact of Qingjian Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjian Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjian Ou more than expected).
Fields of papers citing papers by Qingjian Ou
This network shows the impact of papers produced by Qingjian Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjian Ou. The network helps show where Qingjian Ou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingjian Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 1 | |
| 10 | Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancerbreakdown → | 2023 | 240 |
| 11 | 2023 | 2 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 43 | |
| 15 | 2021 | 46 | |
| 16 | 2020 | 14 | |
| 17 | 2019 | 16 | |
| 18 | 2019 | 17 | |
| 19 | 2017 | 16 | |
| 20 | 2017 | 2 |
About Qingjian Ou
Qingjian Ou is a scholar working on Ophthalmology, Pathology and Forensic Medicine and Oncology, having authored 81 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Development and Disorders (12 papers), Genetic factors in colorectal cancer (10 papers), Retinal Diseases and Treatments (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Nutritional Studies and Diet (8 papers), Corneal Surgery and Treatments (8 papers), Colorectal Cancer Screening and Detection (7 papers) and Diet and metabolism studies (7 papers). The work is most often cited by research in Cancer Research (306 citations), Ophthalmology (88 citations) and Oncology (258 citations). Qingjian Ou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yujing Fang, Zhizhong Pan, Jianhong Peng, Caixia Jin, Lixia Lü, Guo‐Tong Xu, Haibin Tian, Jingying Xu, Zhenhai Lu and Junzhong Lin. Their work appears in journals such as PLoS ONE, Oncogene and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.